Prolonged Oral Morphine Therapy for Severe Angina Pectoris
|
|
- Olivia Carr
- 5 years ago
- Views:
Transcription
1 Vol. 19 No. 5 May 2000 Journal of Pain and Symptom Management 393 Clinical Note Prolonged Oral Morphine Therapy for Severe Angina Pectoris Meir Mouallem, MD, Eli Schwartz, MD, and Zvi Farfel, MD Department of Medicine E, Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel Abstract Patients with intractable angina pectoris despite optimal drug therapy, who are not candidates for revascularization procedures, pose a very difficult problem. We evaluated the role of chronic opioid therapy in four such patients. The patients (mean age 79.5 years) were treated by low doses (mean 40 mg/day) of controlled-release oral morphine () for 1 to 5 years. The treatment was followed by a marked decline in the rate of admissions and hospitalization periods. The number of admissions decreased from a mean of 6 during the year prior to therapy to 1.5 the following year. The duration of hospitalization for angina pectoris during these periods decreased from a mean of days to 6 10 days (p 0.05). Side effects were negligible and consisted mainly of lactulose-responsive constipation. We suggest that prolonged oral morphine therapy may be administered with good efficacy and no significant side effects in selected patients with intractable angina pectoris. J Pain Symptom Manage 2000;19: U.S. Cancer Pain Relief Committee Key Words Intractable angina pectoris, oral morphine Address reprint requests to: Meir Mouallem, MD, Department of Medicine E, Sheba Medical Center, Tel Hashomer 52621, Israel. Accepted for publication: June 17, 1999 Introduction Angina pectoris is a frequent cause of hospital admissions. In most patients, it can be adequately treated by drug therapy or revascularization procedures, such as percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG). In a small minority of patients, pharmacological therapy is insufficient and revascularization procedures are not feasible. These patients with intractable angina pectoris may be admitted repeatedly to the hospital. Various treatment modalities have been proposed for these patients, such as spinal cord stimulation. 1,2 We describe a series of such patients who were treated successfully with oral controlled-release morphine sulphate() for prolonged periods of time. Patients Four patients with severe anginal syndrome that could not be adequately treated medically or surgically were identified (Tables 1 and 2). Patient 1 The patient was 84 years old at the time treatment with started. He had hypertension with mild renal failure (serum creatinine 177 mol/l) and was a past smoker but did not suffer from lung disease. One year earlier, U.S. Cancer Pain Relief Committee, /00/$ see front matter Published by Elsevier, New York, New York PII S (00)
2 394 Mouallem et al. Vol. 19 No. 5 May 2000 Patient Number/ Gender Age at Angina Onset Age at Initiation of 1/M Non Q ant. wall 2/M Inf. wall (16 years). Ant. wall Table 1 Patient Characteristics and Manifestation of Coronary Disease MI (years treatment) CABG Angio Arrhythmia CHF Treatment 0 3VCD Lt main. Normal LV function 15 years Occluded grafts. Native LAD RCA occluded. Cx open and supplies the posterior wall. VPBs Aspirin, Nitrates, Nifedipine, / Heparin CAF Aspirin, Nitrates, / Heparin, Amiodarone then Digoxin, Furosemide Thiazides 3/F N.D. 0 0 Aspirin, Nitrates, Diltiazem 4/F Non Q ant. wall 4 years 3VCD. PTCA to RCA Cx CAVB induced by blockers Aspirin, Nitrates, Ca blockers Angio coronary angiography; Ant anterior; CABG coronary artery bypass graft; CAF chronic atrial fibrillation; CAVB complete atrio ventricular block; CHF congestive heart failure; Cx circumflex artery; F female; Inf Inferior; LAD left anterior descending artery; LIMA left internal mammary artery; LV left ventricle; M male; MI myocardial infarction; N.D. not done; PTCA percutaneous coronary angioplasty; RCA right coronary artery; VPBS ventricular premature beats; 3VCD three vessel coronary artery disease. he had a non-q wave anterior wall myocardial infarction (MI), and since then he had severe anginal syndrome with recurrent admissions to the hospital. He was treated by aspirin, nitrates, calcium blockers, and occasionally by heparin. Coronary angiography demonstrated three vessel coronary artery disease with involvement of the left main coronary artery. There was no option for PTCA and surgery was declined mainly because of his age. The patient was treated by 30 mg/day (10 mg in the morning and 20 mg at bedtime) and had marked improvement, without side effects. During the first year of treatment, the patient was admitted twice because of episodes of non-q wave anterior wall MI that were not masked by the morphine treatment. During that year, he was admitted once more, and, during the following year, there was another admission. The patient continued treatment until his death at the age of 89. Patient 2 The patient was 71 years old when was started. This patient had symptoms of ischemic heart disease since the age of 51. He also had Parkinson s disease and mild renal failure (creatinine 141 mol/l). At the age of 55, the patient had an inferior wall MI and, one year later, CABG was performed with vein grafts to the three coronary vessels. In the year prior to treatment, he was admitted to the hospital 3 times because of severe anginal syndrome and was found to have atrial fibrillation and congestive heart failure (left ventricular ejection fraction 15%). Coronary angiography demonstrated occluded grafts, only the circumflex artery was patent and supplied the posterior wall. The option for PTCA or operation was rejected because of his general condition. The patient has been on treatment for more than 3 years. During these years, he has been admitted only once, for one day, because of anginal pains. Initially, the dose of was 10 mg twice daily; later, the dose was gradually increased to 50 mg twice daily because of increased intensity of the pain. Side effects included severe constipation that was treated successfully by lactulose. In addition, he was admitted once because of confusion induced by the opioid or by the low cardiac output. The patient recovered spontaneously without dose modification. Patient 3 The patient was 81 years old at the time treatment with started. She had Parkinson s disease with recurrent cerebrovascular accidents. Cerebral angiography demonstrated vertebral artery stenosis. Anginal syndrome appeared 9 years prior to treatment and became more severe in the year preceding its initiation. She was treated by aspirin, nitrates and calcium blockers. Nevertheless, in the year prior to treatment, she was admitted 7
3 Vol. 19 No. 5 May 2000 Prolonged Oral Morphine Therapy for Severe Angina 395 Table 2 Admission and Hospitalization Days Due to Angina Pectoris, Related to Treatment with Patient Number Admissions in the year prior to 7 (92) 3 (41) 7 (22) 7 (13) treatment (hospitalization days) Admissions in the first year 3 (21) 1 (1) 1 (1) 1 (1) following therapy Admissions in the second year 1 (1) 0 0 Admissions in the third year 0 1 (1) 0 Treatment duration (years) 5 3, currently 3, currently 1, currently (until death) on Dose of (mg per day) raised to 50 2 on on times to the hospital. The ECG demonstrated sinus bradycardia and left anterior hemiblock; chest radiography, echocardiogram, and thallium scan were normal. The type of the pain and her neurologic abnormalities made us consider the pain as angina. Coronary angiography was not performed and she was treated successfully by 10 mg twice a day. Since then, she was admitted only once because of chest pain and for only one day, following discontinuation by her physician. treatment was accompanied by constipation and was treated successfully by lactulose. The patient had also an episode of biliary colic that could be ascribed to the morphine treatment, which has been administered to her for the last 3 years. Patient 4 The patient was 82 years old when treatment by started. She had hypertension and diabetes, and was a heavy smoker without evidence of chronic obstructive pulmonary disease (COPD). At the age of 78, she began to suffer from anginal pain and CABG was performed, but shortly afterwards the anginal syndrome reappeared and she was treated by aspirin, nitrates, calcium blockers and -blockers, which were discontinued after she had complete atrioventricular block and mild heart failure. Two years treatment, coronary angiography was performed and threevessel coronary disease was demonstrated. PTCA to the right coronary artery and to the circumflex artery was performed, but the patient continued to suffer from intractable angina. In the year prior to treatment, she was admitted 7 times to the hospital. She has been treated by 10 mg twice daily, and, in the first year of treatment, she has been admitted only once, due to temporary discontinuation of the medication. She has been tolerating the treatment very well and has had no side effects. Table 1 shows the clinical data regarding the patients coronary artery disease. Table 2 shows the response of the patients to the treatment. It is clear that after initiation of therapy, there was a marked decline in the number and duration of hospitalizations due to angina. The number of hospitalizations decreased from a mean of 6 during the year prior to therapy to a mean of 1.5 the following year. The total duration of hospitalizations during the year prior to decreased from a mean of days to a mean of 6 10 days the following year (p 0.05). During this period, the patients were not hospitalized on other wards. Discussion Prolonged treatment of patients with angina pectoris by epidural morphine infusion was first reported by Clemensen et al in They described 7 patients with intractable angina which lasted for 1 10 years and had failed revascularization procedures. In response to the epidural morphine, which was administered by the patients or by family members, the pain decreased in all patients for a follow-up period of 3 11 months. Two other patients treated by epidural morphine administration
4 396 Mouallem et al. Vol. 19 No. 5 May 2000 or by continuous intrathecal infusion of morphine were described later. 4,5 Since increased use of systemic morphine for nonmalignant conditions has become more prevalent and acceptable, 6,7 we decided to treat patients with intractable angina who were not candidates for revascularization by this modality. Our patients are the first described group with intractable angina treated with oral opioids for a prolonged time. All the patients had severe anginal symptoms and severe coronary artery disease was demonstrated by coronary angiography in three. Two had failed CABG and none was a candidate for a revascularization procedure. One patient (number 3) had a stroke in the past and Parkinson s disease, and invasive procedures were, therefore, not performed. These patients were relatively old. Three were in their eighties and one was 71 years at the beginning of treatment. In contrast to the relatively short duration of epidural morphine therapy described earlier (a few months), 3 our patients were treated for prolonged periods, 1 5 years, with a mean follow up of 3 years. Although this was not a controlled study, it was obvious that treatment with morphine significantly improved the quality of life of the patients. The patients reported a definite decline in the number and intensity of the anginal episodes. The number and duration of hospitalizations decreased dramatically in all the patients. The first patient who was admitted more times than the other patients during the first year of treatment was admitted twice because of non-q wave anterior wall MI. The third and the fourth patients were admitted only once and for only one day during the first year of treatment. The cause of admissions in both patients was discontinuation because their family physicians avoided prescription of. A few issues should be considered regarding prolonged oral opioid therapy in angina pectoris. No patient developed tolerance to the drug, and the low doses of used were usually constant. Dose increase was not observed also in patients who were treated intrathecally or epidurally. 3,5 This differs from patients with malignant disease in whom the intensity of the pain increases over time, with consequent requirement for escalation of the opioid dose. It is conceivable that in patients with anginal syndrome, the intensity of the pain is relatively constant and there is apparently no need to increase the dose of the drug. In only one patient (number 2), the dose of was escalated because of increased pain intensity. Side effects seen in the treatment group were relatively insignificant. As is common in patients treated with opioids, two of the patients had constipation necessitating treatment with lactulose. The second patient had an episode of confusion that could be ascribed to treatment or to the severity of heart failure. It is also possible that abdominal pain and biliary colic that caused hospitalization in the third patient were induced by treatment with morphine. Can therapy mask ischemic episodes? 5,8 Because the group is small, it is difficult to address this issue. However, Patient 1 had two ischemic episodes that were recognized by him and were not masked by the treatment. Moreover, even if ischemic episodes were masked, they did not cause myocardial infarction. Of note is the long survival of these elderly patients. It is obvious that such a nonconventional treatment should be undertaken only after detailed discussion with the patients, their families, and their physicians. Clarification that this kind of therapy can be used although no malignancy is being treated is very important for the success of this unorthodox therapy. From the small series of patients here described, it seems that prolonged oral morphine therapy for intractable angina can be administered with good efficacy and negligible side effects in selected patients. Large series will be required to better define the indication for such therapy and the mechanism of its beneficial effect. References 1. Jessurun GAJ, DeJongste MJL, Blanksma PK. Current views on neurostimulation in the treatment of cardiac ischemic syndromes. Pain 1996;66: Hautvast RWM, Brouwer J, DeJongste MJL, Lie KI. Effect of spinal cord stimulation on heart rate variability and myocardial ischemia in patients with chronic intractable angina pectoris a prospective ambulatory electrocardiographic study. Clin Cardiol 1998;21:33 38.
5 Vol. 19 No. 5 May 2000 Prolonged Oral Morphine Therapy for Severe Angina Clemensen SF, Thayssen P, Hole P. Epidural morphine for outpatients with severe anginal pain. Br Med J 1987;294: Cherry DA, Gourlay GK. CT contrast evidence of injectate encapsulation after long-term epidural administration. Pain 1992;49: Segal R, Murali S, Tipton K. Treatment of chronic unstable angina pectoris: use of a totally implantable programmable device for continuous intrathecal infusion of opiates: case report. Neurosurgery 1996;38: Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 1996;11: Brookoff D, Polomano R. Treating sickle cell pain like cancer pain. Ann Intern Med 1992;116: Dershwitz M, Sherman EP. Acute myocardial infarction symptoms masked by epidural morphine? J Clin Anesth 1991;3:
Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationWhy is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager
Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient in addition
More informationCase Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?
Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More informationWhy is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme
Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationWHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.
WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:
More informationHEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
More informationCommon Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
More informationAcute Myocardial Infarction. Willis E. Godin D.O., FACC
Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More information1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown
Medical-Surgical Nursing Care Second Edition Karen Burke Priscilla LeMone Elaine Mohn-Brown Chapter 26 Caring for Clients with Coronary Heart Disease and Dysrhythmias Coronary Heart Disease (CHD) Leading
More informationLnformation Coverage Guidance
Lnformation Coverage Guidance Coverage Indications, Limitations, and/or Medical Necessity Abstract: B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle. It
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationCase Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA
Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after
More informationCandesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
1/5 This site became the new ClinicalTrials.gov on June 19th. Learn more. We will be updating this site in phases. This allows us to move faster and to deliver better services. Show less IMPORTANT: Listing
More informationAcute Myocardial Infarction
Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:
More informationChapter (9) Calcium Antagonists
Chapter (9) Calcium Antagonists (CALCIUM CHANNEL BLOCKERS) Classification Mechanism of Anti-ischemic Actions Indications Drug Interaction with Verapamil Contraindications Adverse Effects Treatment of Drug
More informationMedicine Dr. Omed Lecture 2 Stable and Unstable Angina
Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel
More informationForm 4: Coronary Evaluation
Form : Coronary Evaluation Print this Form t Started Date of Coronary Evaluation Coronary Evaluation Indication for Coronary Evaluation Check only one. Angio NOT DONE: n invasive test performed Followup
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationAPPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationSevere Coronary Vasospasm Complicated with Ventricular Tachycardia
Severe Coronary Vasospasm Complicated with Ventricular Tachycardia Göksel Acar, Serdar Fidan, Servet İzci and Anıl Avcı Kartal Koşuyolu High Specialty Education and Research Hospital, Cardiology Department,
More informationECG in coronary artery disease. By Sura Boonrat Central Chest Institute
ECG in coronary artery disease By Sura Boonrat Central Chest Institute EKG P wave = Atrium activation PR interval QRS = Ventricle activation T wave= repolarization J-point EKG QT interval Abnormal repolarization
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationThe MAIN-COMPARE Registry
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions
Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main
More informationSCS in angina pectoris
SCS in angina pectoris STOCKHOLM 100829 Mats Borjesson, FESC MD, PhD, assoc prof Goteborg, Sweden Paincenter, Dept of Medicine Sahlgrenska University Hospital/Östra, Göteborg, Sweden Refractory Angina
More informationCoronary arteriography in complicated acute myocardial infarction; clinical and angiographic correlates
Coronary arteriography in complicated acute myocardial ; clinical and angiographic correlates Luis M. de la Fuente, M.D. Buenos Aires, Argentina From January 1979 to June 30, 1979, we performed coronary
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33200-37186, 37195-37785, 92950-93272, 93303-93581,
More informationCardiology/Cardiothoracic
Cardiology/Cardiothoracic ICD-9-CM to ICD-10-CM Code Mapper 800-334-5724 www.contexomedia.com 2013 ICD-9-CM 272.0 Pure hypercholesterolemia 272.2 Mixed hyperlipidemia 272.4 Other and hyperlipidemia 278.00
More informationCurrent Management of Coronary Artery Disease with Special Emphasis on the Elderly and Diabetic
Current Management of Coronary Artery Disease with Special Emphasis on the Elderly and Diabetic Dr Albert Ko FRACP, FCSANZ Interventional Cardiologist Ascot Angiography Auckland, New Zealand Diagnosis
More informationForm 4: Coronary Evaluation
Patient Details Hidden Show Show/Hide Annotations Form : Coronary Evaluation Print this Form t Started Date of Coronary Evaluation Coronary Evaluation Indication for Coronary Evaluation Check only one.
More informationDUKECATHR Dataset Dictionary
DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of
More informationIHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the
More informationListing Form: Heart or Cardiovascular Impairments. Medical Provider:
Listing Form: Heart or Cardiovascular Impairments Medical Provider: Printed Name Signature Patient Name: Patient DOB: Patient SS#: Date: Dear Provider: Please indicate whether your patient s condition
More informationIschaemic heart disease. IInd Chair and Clinic of Cardiology
Ischaemic heart disease IInd Chair and Clinic of Cardiology Definition Syndrome due to chronic insufficient oxygen supply to myocardial cells Nomenclature: ischaemic heart disease (IHD), coronary artery
More informationProcess Measure: Screening for Adult Obstructive Sleep Apnea
Process Measure: Screening for Adult Obstructive Sleep Apnea Measure Description Description Type of Measure All patients aged 18 years and older at high risk for obstructive sleep apnea (OSA) with documentation
More informationOUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION
OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,
More informationMyth or Real? The Potential Serious Side Effects of Ticagrelor
447 International Journal of Collaborative Research on Internal Medicine & Public Health Myth or Real? The Potential Serious Side Effects of Ticagrelor Wassam EL Din Hadad EL Shafey* Cardiology Department,
More information(For items 1-12, each question specifies mark one or mark all that apply.)
Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:
More informationAbnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)
Background: Reason: preoperative assessment of CAD, Shortness of Breath Symptom: atypical chest pain Risk factors: hypertension Under influence: a beta blocker Medications: digoxin Height: 66 in. Weight:
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33361-33369, 33200-37186, 37195-37785, 92950-93272,
More informationAutomatic External Defibrillators
Last Review Date: April 21, 2017 Number: MG.MM.DM.10dC3v4 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationDetailed Order Request Checklists for Cardiology
Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018
More informationUPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18
UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment
More informationARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:
ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to
More informationRational use of imaging for viability evaluation
EUROECHO and other imaging modalities 2011 Rational use of imaging for viability evaluation Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology, CHU Liège, Belgium
More informationResults of Ischemic Heart Disease
Ischemic Heart Disease: Angina and Myocardial Infarction Ischemic heart disease; syndromes causing an imbalance between myocardial oxygen demand and supply (inadequate myocardial blood flow) related to
More informationUse of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users
Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users February 1 5, 2011 University of Santo Tomas Hospital Angelo King A-V Auditorium Manila,
More informationCardiovascular Diseases and Diabetes
Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular
More informationCardiology Documentation in an ICD-10 World
Cardiology Documentation in an ICD-10 World Providence Little Company of Mary Medical Center - Torrance July 10, 2015 Andrew H. Dombro, MD Internist/Hospitalist Regional Medical Director JA Thomas, a Nuance
More informationPerioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30
Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30 Active Cardiac Conditions for Which the Patient Should Undergo Evaluation
More informationAn Approach to the Patient with Syncope. Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva
An Approach to the Patient with Syncope Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva Case presentation A 23 y.o. man presented with 2 episodes of syncope One during exercise,one at rest
More information2018 HPN Provider Summary Guide. Adult Cardiology Patients (18 Years and Older) Referral Guidelines
12.2 CARDIOLOGY REFERRAL GUIDELINES Contracted Group: Southwest Medical Associates For Appointments: 888 S. Rancho Las Vegas, NV 89109 Phone: (702) 877-8654 Fax: (702) 242-7998 Adult Cardiology Patients
More informationTitle: Automatic External Defibrillators Division: Medical Management Department: Utilization Management
Retired Date: Page 1 of 7 1. POLICY DESCRIPTION: Automatic External Defibrillators 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management, Pharmacy,
More informationEvidence-Based Management of CAD: Last Decade Trials and Updated Guidelines
Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33361-33369, 33200-37186, 37195-37785, 92950-93272,
More informationCMS Limitations Guide - Cardiovascular Services
CMS Limitations Guide - Cardiovascular Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationAlex versus Xience Registry Preliminary report
Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor
More informationCMS Limitations Guide - Cardiovascular Services
CMS Limitations Guide - Cardiovascular Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationDISCUSSION QUESTION - 1
CASE PRESENTATION 87 year old male No past history of diabetes, HTN, dyslipidemia or smoking Very active Medications: omeprazole for heart burn Admitted because of increasing retrosternal chest pressure
More informationCASE from South Korea
CASE from South Korea Bon-Kwon Koo, MD, PhD, Seoul, Korea Outpatient clinic of a non-interventional cardiologist F/56 Chief complaint: Angina with recent aggravation, CCS II~III Brief history: # Stroke
More information10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor
Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationOutpatient Cardiac Rehabilitation
Last Review Date: May 12, 2017 Number: MG.MM.ME.26bC3v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationElectrocardiography. Hilal Al Saffar College of Medicine,Baghdad University
Electrocardiography Hilal Al Saffar College of Medicine,Baghdad University Which of the following is True 1. PR interval, represent the time taken for the impulse to travel from SA node to AV nose. 2.
More informationZachary I. Hodes, M.D., Ph.D., F.A.C.C.
Zachary I. Hodes, M.D., Ph.D., F.A.C.C. Disclamer: I personally have no financial relationship with any company mentioned today. The Care Group, LLC does have a contract with Cardium to participate in
More informationCORONARY ARTERY BYPASS GRAFT
CORONARY ARTERY BYPASS GRAFT Coronary artery disease develops because of hardening of the arteries (arteriosclerosis) that supply blood to the heart muscle. In the diagnosis of coronary artery disease,
More informationCHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand
CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand ENHANCED EXTERNAL COUNTER PULSATION Piyanuj Ruckpanich, MD. Cardiac Rehabilitation Center Perfect
More informationCardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention
Cardiology Self Learning Package Module 5: Pharmacology: Treatment of Acute Coronary Syndromes, Module 5: Pharmacology: Hyperlipidaemia, Treatment of Acute Coronary Hypertension, Symdrome, Hyperlipidaemia,
More informationParis, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators
Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo
More informationCoronary Artery Disease: Revascularization (Teacher s Guide)
Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention
More informationTranscatheter closure of right coronary artery fistula to the right ventricle
Case Report Transcatheter closure of right coronary artery fistula to the right ventricle Abstract Coronary artery fistula (CAF) is an uncommon anomaly usually congenital but can be acquired. Although,
More informationTranscoronary Chemical Ablation of Atrioventricular Conduction
757 Transcoronary Chemical Ablation of Atrioventricular Conduction Pedro Brugada, MD, Hans de Swart, MD, Joep Smeets, MD, and Hein J.J. Wellens, MD In seven patients with symptomatic atrial fibrillation
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,
More informationAPPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10
Ross JS, Bernheim SM, Lin Z, Drye EE, Chen J, Normand ST, et al. Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. Health Aff (Millwood).
More informationAtrial fibrillation (AF) is a disorder seen
This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,
More informationRecording and Evaluation of Co-Morbidity - An Update. Jill Birch University of Manchester
Recording and Evaluation of Co-Morbidity - An Update Jill Birch University of Manchester Introduction Co-morbidity included in Adult cancer datasets from outset Measures to be used uncertain Uncertainty
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationCHRONIC CAD DIAGNOSIS
CHRONIC CAD DIAGNOSIS Chest Pain Evaluation 1. Approach to diagnosis of CAD 2. Classification of chest pain 3. Pre-test likelihood CAD 4. Algorithm for chest pain evaluation in women 5. Indications for
More informationInterQual Care Planning SIM plus Criteria 2014 Clinical Revisions
InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions The Clinical Revisions provide details of changes to InterQual Clinical Criteria. They do not provide information on changes made to CareEnhance
More information8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None
Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac
More informationTHE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease
THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation
More informationLecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors
Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life
More informationVentricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center
Ventricular tachycardia and ischemia Martin Jan Schalij Department of Cardiology Leiden University Medical Center Disclosure: Research grants from: Boston Scientific Medtronic Biotronik Sudden Cardiac
More information4. Which survey program does your facility use to get your program designated by the state?
STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI
More informationCMS Limitations Guide - Cardiovascular Services
CMS Limitations Guide - Cardiovascular Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationType of intervention Diagnosis. Economic study type Cost-effectiveness analysis.
The utility and potential cost-effectiveness of stress myocardial perfusion thallium SPECT imaging in hospitalized patients with chest pain and normal or non-diagnostic electrocardiogram Ben-Gal T, Zafrir
More informationAppendix 1: Supplementary tables [posted as supplied by author]
Appendix 1: Supplementary tables [posted as supplied by author] Table A. International Classification of Diseases, Ninth Revision, Clinical Modification Codes Used to Define Heart Failure, Acute Myocardial
More information2017 Cardiology Survival Guide
2017 Cardiology Survival Guide Chapter 4: Cardiac Catheterization/Percutaneous Coronary Intervention A cardiac catheterization involves a physician inserting a thin plastic tube (catheter) into an artery
More informationCORONARY ARTERY DISEASES
CORONARY ARTERY DISEASES It has been estimated that over one third of the population eventually will die of CAD, and 20% will develop symptoms when younger than age 60 years. ANATOMY OF THE CORONARY ARTERIES
More informationMedical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI
Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the
More informationTSDA ACGME Milestones
TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short
More informationAF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management
AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan
More informationAtrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018
Atrial Fibrillation and the NOAC s John Raymond MS, PA-C, MHP February 10, 2018 Pathogenesis EPIDEMIOLOGY Arrhythmia-related hospitalisations in the US Ventricular fibrillation 2% Atrial fibrillation 34%
More informationCLINCIAL APPLICATION OF GUIDELINES IN HEART FAILURE
CLINCIAL APPLICATION OF GUIDELINES IN HEART FAILURE SSC Journée d Automne 25 novembre 2010 Dr. Charles Seydoux, spéc. FMH en médecine interne et en cardiologie, Lausanne Dr. Claudia Bösch, Oberärztin Herzinsuffizienz
More information